This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Why could we see more deal-making at this year’s J. P. Morgan Healthcare conference? Why are investors concerned about a slowdown in U.S. biotech innovation? And what are the hosts’ New Year’s resolutions? We discuss all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast.
EXCLUSIVE Seven in 10 pharmacists working in general practice or primary care networks (PCNs) see themselves working in the sector in five years' time, our snapshot survey has suggested. Almost 250 pharmacists working in general practice or community settings were asked about their career intentions in the coming years, as part of a survey carried […] The post Majority of practice pharmacists plan to stay in sector in five years' time appeared first on The Pharmacist.
Candel Therapeutics’ CEO had to prioritize a phase 3 program amid layoffs and cuts, and an end-of-year clinical success was the redemption he was looking for.
PCN pharmacist Gurvinder Najran shares insights into the role of a pharmacist PCN engagement lead and the outcomes of a 12-month hypertension case-finding pilot study Q. Tell us about your role as primary care engagement lead and your support for community pharmacy I serve as a primary care prescribing pharmacist within general practice, and I […] The post Working with community pharmacy as primary care engagement lead appeared first on The Pharmacist.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Lupin Limited announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Ivacaftor Oral Granules in 25 mg, 50 mg, and 75 mg per unit dose packet. The product is a generic equivalent of Kalydeco Oral Granules by Vertex Pharmaceuticals Incorporated.
PVT401 is said to be the second autoimmune drug candidate from Parvus. Parvus is focused on developing peptide-major histocompatibility complex (pMHC) nanomedicine drugs. These assets can activate in vivo generation of antigen-specific Treg cells thereby stopping and curing autoimmune disease. It works by restoring organ-specific immune tolerance without conceding systemic immunity.
By Anne K. Walsh & Hyman, Phelps & McNamara, P.C. & Douglas B. Farquhar This is the first in a series of blog posts on tips for successfully handling an FDA inspection. Using publicly available examples, these lessons will illustrate potential pitfalls and strategies for interacting with FDA during and after an inspection. Although FDA has long taken the position that it has broad authority in how it conducts its inspections, it was not until 2012 that Congress put some teeth behind
By Anne K. Walsh & Hyman, Phelps & McNamara, P.C. & Douglas B. Farquhar This is the first in a series of blog posts on tips for successfully handling an FDA inspection. Using publicly available examples, these lessons will illustrate potential pitfalls and strategies for interacting with FDA during and after an inspection. Although FDA has long taken the position that it has broad authority in how it conducts its inspections, it was not until 2012 that Congress put some teeth behind
The International Drug Development Institute (IDDI) has announced changes to its executive leadership team to strengthen the companys leadership and operational capabilities. Tim Davis has been announced as chief executive officer, bringing over 25 years of experience to the role. Tim has previously worked in the pharmaceutical, life sciences and digital health sectors, leading strategic […] The post IDDI announces two new appointments to its leadership team appeared first on Pharmafile.
Three industry bodies have produced a joint position paper highlighting recommendations for adopting a harmonised implementation of electronic Product Information (ePI) leaflets. The electronic Product Information] ePI platform will serve as a single source of trustworthy information, fostering transparency and regulatory efficiency across the EU The pharmaceutical industry associations, European Federation Of Pharmaceutical Industries and Associations (EFPIA), Medicines for Europe and Associati
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The biotech will stop developing two drugs and lay off nearly three-quarters of its staff after its lead therapy wasn’t as potent in early testing as the company expected.
The following blog is written by Epicur Pharmas Advisory Council member Nicole Clausen, CSSGB, CCFP. With over 15 years of experience in the veterinary industry, Nicole understands a successful practice’s operations, intricacies, and internal workingsincluding sustainable inventory management strategies. Nicole shares her perspective on the importance of choosing the right compounding pharmacy to successfully manage your practices inventory.
The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with menopause as well as a common breast cancer therapy.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Honoring the Vital Role of Virtual Clinical Pharmacists National Pharmacist Day , recognized annually on January 12, underscores the critical role pharmacists play in advancing patient safety and delivering comprehensive, patient-centered care. Beyond dispensing medications, pharmacists serve as integral members of care teams, providing patient education, minimizing medication errors and advocating for better health outcomes.
The newly launched biotech is equipped with rights to a trio of weight loss medicines licensed from China-based Sciwind Biosciences, led by an oral therapy ready for Phase 2 testing.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Navigating the complex landscape of drug development and manufacturing can be a daunting task. Enter the Contract Development and Manufacturing Organization (CDMO) a lifeline for many startups looking to bring their innovative therapies to market. But how do you, as a startup, ensure you’re making the most of this crucial partnership? Let’s dive into the best CDMO practices that can set your startup on the path to success.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Researchers at the Experimental and Clinical Research Center in Berlin are developing a targeted treatment for muscular dystrophy with the help of gene-editing. Preclinical research led by the Spuler Lab published in Nature Communications now paves the way for first-in-human clinical trials. Researchers at the Experimental and Clinical Research Center (ECRC), a joint institution of the Max Delbrck Center and Charit - Universittsmedizin Berlin, have developed a promising gene-editing approach int
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Newly launched company, Verdiva Bio, is aiming to advance oral and injectable drugs for obesity, with it backed by an oversubscribed Series A financing round of $411m.
Nearly 30% of the funding poured into healthcare startups last year, including for biotechs, went to companies leveraging artificial intelligence, according to Silicon Valley Bank.
CNP-104 is a biodegradable nanoparticle that previously received fast track designation from FDA in January 2022, which would eventually make it eligible for accelerated approval and priority review.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content